NCT05652686 2025-09-23A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)Phanes TherapeuticsPhase 1/2 Recruiting203 enrolled
NCT03992911 2019-06-20Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine CarcinomaPeking UniversityPhase 2/3 Unknown336 enrolled